Skip to content
  • info@bridgewaycp.com
  • NEWS & EVENTS
  • CAREERS
  • NEWS & EVENTS
  • About Us
  • Senior Leadership
  • Services
    • Investment Banking
    • Strategic Capital
    • IPO Advisory
    • Principal Investment
  • Contact Us
  • Loading stock data...

News & Events

Date

News

May 16, 2022

Bright Green to Commence Trading on Nasdaq on May 17, 2022

Apr 19, 2022

Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement

Mar 21, 2022

Statera Biopharma Announces Proposed Underwritten Public Offering

Dec 2, 2021

EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement

Aug 18, 2021

Captura Biopharma Secures $50 Million Investment Commitment from GEM as Company Seeks to Go Public in Coming Months

Jul 29, 2021

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

Jul 28, 2021

Cytocom Inc. Announces Completed Merger with Cleveland BioLabs

Jul 22, 2021

HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering

Jul 09, 2021

Vinings Holdings, Inc. to be Renamed Coeptis Therapeutics, Inc.

Apr 15, 2021

Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

Oct 19, 2020

Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement

Interested? Let's do this together​

Bridgeway can help you execute on your strategic goals.
Get started

Learn more about Bridgeway Capital Partners

Securities transactions offered through Entoro Securities, LLC. Member FINRA and SIPC.

Navigation

  • About Us
  • Senior Leadership
  • Contact Us
  • FINRA BrokerCheck
  • Investment Banking
  • Strategic Capital
  • IPO Advisory
  • Principal Investment

Contact Us

© 2020 All rights reserved​, Bridgeway Capital Partners | Privacy Policy  Terms of Use

Made with ❤ by Topic Flip